The Enterprise Value as of June 2026 (TTM) for Greenwich LifeSciences, Inc. (GLSI) is 342.65M

According to Greenwich LifeSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 342.65M. This represents a change of 55.26% compared to the average of 220.69M of the last 4 quarters.

Greenwich LifeSciences, Inc. (GLSI) Historical Enterprise Value (quarterly & annually)

How has GLSI Enterprise Value performed in the past?

The mean historical Enterprise Value of Greenwich LifeSciences, Inc. over the last ten years is 182.74M. The current 342.65M Enterprise Value has changed 18.65% with respect to the historical average. Over the past ten years (40 quarters), GLSI's Enterprise Value was at its highest in in the June 2021 quarter at 549.74M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Greenwich LifeSciences, Inc. (GLSI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Greenwich LifeSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Greenwich LifeSciences, Inc. (GLSI) Average Enterprise Value

How has GLSI Enterprise Value performed in the past?

The current Enterprise Value of Greenwich LifeSciences, Inc. (GLSI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Greenwich LifeSciences, Inc. (GLSI) Enterprise Value vs. Peers

How is GLSI’s Enterprise Value compared to its peers?

Greenwich LifeSciences, Inc.’s Enterprise Value is greater than Cognition Therapeutics, Inc. (58.37M), greater than Atossa Therapeutics, Inc. (-10533885.00), greater than Tevogen Bio Holdings Inc. (46.22M), greater than Oncolytics Biotech Inc. (107.76M), greater than Surrozen, Inc. (74.76M), greater than TuHURA Biosciences, Inc. (141.90M), greater than Seer, Inc. (70.28M), greater than Opus Genetics, Inc. (294.81M), less than Agenus Inc. (406.89M), less than Immix Biopharma, Inc. (381.48M),

Build a custom stock screener for Greenwich LifeSciences, Inc. (GLSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenwich LifeSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Greenwich LifeSciences, Inc. (GLSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Greenwich LifeSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.